Ferronordic AB
STO:FNM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ferronordic AB
STO:FNM
|
SE |
|
L
|
Lytix Biopharma AS
F:6BG
|
NO |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FNM's stock price target?
Not Available
FNM doesn't have any price targets made by Wall Street professionals.
What is Ferronordic AB's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Ferronordic AB's revenue is
5%.
The projected
CAGR
for the next 3 years is
6%.
What is Ferronordic AB's Operating Income forecast?
Projected CAGR
40%
For the last 13 years the
compound annual growth rate for
Ferronordic AB's operating income is
10%.
The projected
CAGR
for the next 3 years is
40%.